{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:04:33Z","timestamp":1789452273318,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Geriatric team, Department of Medicine, Queen Mary Hospital, Hong Kong"},{"DOI":"10.13039\/501100003802","name":"University Research Committee, University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The neurovascular effects of anti-amyloid therapy remain incompletely understood. Arterial spin labeling (ASL) MRI enables non-invasive quantification of regional cerebral blood flow (rCBF) and may provide insight into perfusion patterns observed over the treatment period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This pilot observational case series included participants with MCI or very early Alzheimer\u2019s disease undergoing anti-amyloid therapy (lecanemab), who underwent longitudinal pseudo-continuous ASL MRI at baseline and predefined follow-up timepoints. Regional rCBF was quantified across predefined cortical and subcortical regions of interest. A comparison group of amyloid-positive participants with MCI who did not receive anti-amyloid therapy underwent baseline ASL MRI. Vascular and metabolic risk factors, including white matter hyperintensity burden and biochemical parameters, were assessed to characterize potential confounding influences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within the treated group, increased rCBF was observed at early follow-up in several frontal, sensorimotor, and subcortical regions. No statistically significant longitudinal changes were detected at intermediate follow-up. At later follow-up, increased rCBF was observed in the cerebellar cortex, while decreased rCBF was observed in bilateral medial temporal regions. Vascular and metabolic risk profiles, including WMH burden, were broadly comparable between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The observed rCBF trajectories demonstrate region-specific and time-dependent perfusion changes over the treatment period. Given the small sample size, absence of longitudinal imaging in the control group, and residual vascular confounding, these findings should be interpreted cautiously as exploratory and hypothesis-generating rather than evidence of treatment efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1903239","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:35:54Z","timestamp":1789450554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal patterns of regional cerebral blood flow during anti-amyloid therapy in mild cognitive impairment: a pilot ASL MRI case series"],"prefix":"10.3389","volume":"18","author":[{"given":"Eva Y. W.","family":"Cheung","sequence":"first","affiliation":[{"name":"Department of Diagnostic Radiology, LKS Faculty of Medicine, The University of Hong Kong","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yat Fung","family":"Shea","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, Queen Mary Hospital","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K. C.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, Queen Mary Hospital","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon Ho","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, Queen Mary Hospital","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Sciences, The Hong Kong Polytechnic University","place":["Kowloon, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Keung","family":"Yam","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, Queen Mary Hospital","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongtae T.","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, LKS Faculty of Medicine, The University of Hong Kong","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry K. F.","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, LKS Faculty of Medicine, The University of Hong Kong","place":["Pokfulam, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00406-011-0226-2","article-title":"Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer\u2019s disease measured by pulsed arterial spin labeling MRI","volume":"262","author":"Alexopoulos","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3233\/JAD-2010-091699","article-title":"Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer\u2019s disease","volume":"20","author":"Alsop","year":"2010","journal-title":"J. Alzheimer's Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mrm.25197","article-title":"Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia","volume":"73","author":"Alsop","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"ref4","first-page":"3708","article-title":"2024 Alzheimer\u2019s disease facts and figures","volume-title":"Alzheimers Dement","year":"2024"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/alz.039257","article-title":"Association of amyloid load uptake and cerebral blood flow in non-Alzheimer\u2019s disease dementia and mild cognitive impairment: neuroimaging \/ normal brain aging","volume":"16","author":"Chau","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias","volume":"19","author":"Ch\u00e9telat","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"Freesurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"NeuroImage"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000524797","article-title":"Regional cerebral blood flow changes in healthy ageing and Alzheimer\u2019s disease: a narrative review","volume":"52","author":"Graff","year":"2023","journal-title":"Cerebrovasc. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1148\/radiol.2016150789","article-title":"Arterial spin labeling perfusion of the brain: emerging clinical applications","volume":"281","author":"Haller","year":"2016","journal-title":"Radiology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.neuron.2010.10.020","article-title":"Transsynaptic progression of amyloid-\u03b2-induced neuronal dysfunction within the entorhinal-hippocampal network","volume":"68","author":"Harris","year":"2010","journal-title":"Neuron"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat. Commun."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","article-title":"Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease","volume":"140","author":"Korte","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1345251","DOI":"10.3389\/fnagi.2024.1345251","article-title":"A 3D pseudo-continuous arterial spin labeling study of altered cerebral blood flow correlation networks in mild cognitive impairment and Alzheimer\u2019s disease","volume":"16","author":"Li","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3174\/ajnr.A8654","article-title":"Antiamyloid therapy and cerebral blood flow changes on MRI: a potential longitudinal biomarker of treatment response?","volume":"46","author":"Ricaurte-Fajardo","year":"2025","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2018.07.005","article-title":"The cerebellum and cognition","volume":"688","author":"Schmahmann","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5479597","article-title":"Regional cerebral blood flow in mild cognitive impairment and Alzheimer\u2019s disease measured with arterial spin labeling magnetic resonance imaging","volume":"2017","author":"Sierra-Marcos","year":"2017","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.neuroimage.2011.08.049","article-title":"Altered spontaneous activity in Alzheimer\u2019s disease and mild cognitive impairment revealed by regional homogeneity","volume":"59","author":"Zhang","year":"2012","journal-title":"NeuroImage"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"630382","DOI":"10.3389\/fnagi.2021.630382","article-title":"Altered regional cerebral blood flow and brain function across the Alzheimer\u2019s disease Spectrum: a potential biomarker","volume":"13","author":"Zhang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fnins.2019.00738","article-title":"Disrupted regional cerebral blood flow, functional activity and connectivity in Alzheimer\u2019s disease: a combined ASL perfusion and resting state fMRI study","volume":"13","author":"Zheng","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1903239\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:35:55Z","timestamp":1789450555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1903239\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":21,"alternative-id":["10.3389\/fnagi.2026.1903239"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1903239","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1903239"}}